Quest Pharmatech Stock Net Asset
| QPT Stock | CAD 0.04 0.01 33.33% |
Quest PharmaTech fundamentals help investors to digest information that contributes to Quest PharmaTech's financial success or failures. It also enables traders to predict the movement of Quest Stock. The fundamental analysis module provides a way to measure Quest PharmaTech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Quest PharmaTech stock.
Quest |
Quest PharmaTech Company Net Asset Analysis
Quest PharmaTech's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Quest PharmaTech Net Asset | 84.36 M |
Most of Quest PharmaTech's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Quest PharmaTech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, Quest PharmaTech has a Net Asset of 84.36 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all Canada stocks is notably lower than that of the firm.
Quest Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Quest PharmaTech's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Quest PharmaTech could also be used in its relative valuation, which is a method of valuing Quest PharmaTech by comparing valuation metrics of similar companies.Quest PharmaTech is currently under evaluation in net asset category among related companies.
Quest Fundamentals
| Return On Equity | -0.29 | |||
| Return On Asset | -0.0094 | |||
| Current Valuation | 6.83 M | |||
| Shares Outstanding | 169.13 M | |||
| Shares Owned By Insiders | 17.12 % | |||
| Number Of Shares Shorted | 530 | |||
| Price To Earning | (3.09) X | |||
| Price To Book | 0.08 X | |||
| Price To Sales | 515.97 X | |||
| EBITDA | (7.3 M) | |||
| Net Income | (7.33 M) | |||
| Cash And Equivalents | 4.41 M | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 1000 K | |||
| Current Ratio | 0.40 X | |||
| Book Value Per Share | 0.39 X | |||
| Cash Flow From Operations | (554.68 K) | |||
| Earnings Per Share | (0.12) X | |||
| Number Of Employees | 11 | |||
| Beta | 0.29 | |||
| Market Capitalization | 5.92 M | |||
| Total Asset | 84.36 M | |||
| Retained Earnings | 41.49 M | |||
| Working Capital | (484.9 K) | |||
| Five Year Return | 32.58 % | |||
| Net Asset | 84.36 M |
About Quest PharmaTech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Quest PharmaTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Quest PharmaTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Quest PharmaTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Quest PharmaTech using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quest PharmaTech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for Quest Stock analysis
When running Quest PharmaTech's price analysis, check to measure Quest PharmaTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest PharmaTech is operating at the current time. Most of Quest PharmaTech's value examination focuses on studying past and present price action to predict the probability of Quest PharmaTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest PharmaTech's price. Additionally, you may evaluate how the addition of Quest PharmaTech to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |